Rafael Bejar
Directeur Technique/Scientifique/R&D chez APTOSE BIOSCIENCES INC.
Fortune : 8 506 $ au 30/04/2024
Provenance du réseau au premier degré de Rafael Bejar
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Rafael Bejar via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| IBM | Packaged Software | Corporate Officer/Principal | |
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Graduate Degree | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director of Finance/CFO | |
| CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO | |
| ONCOLYTICS BIOTECH INC. | Biotechnology | Director/Board Member Director/Board Member | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
ROTH Capital Partners LLC
 ROTH Capital Partners LLC Investment Banks/BrokersFinance ROTH Capital Partners LLC is a broker/dealer headquartered in Newport Beach, California. The firm was founded in 2001 and is a subsidiary of CR Financial Holdings, Inc. They offer institutional sales and trading services. Their broad institutional coverage includes investors in North America, Canada, UK, Europe and other international territories. | Investment Banks/Brokers | Analyst-Equity | |
| Emory University | College/University | Doctorate Degree | |
St. Luke's Episcopal Hospital
 St. Luke's Episcopal Hospital Hospital/Nursing ManagementHealth Services St. Luke's Episcopal Hospital provides medical and healthcare services. Its services include home health care, outpatient, surgical, cancer care, pulmonary care, rehabilitation therapy, and other health care services. The company was founded in 1954 and is headquartered in Houston, TX | Hospital/Nursing Management | Corporate Officer/Principal | |
| PROMIS NEUROSCIENCES, INC. | Biotechnology | Director of Finance/CFO | |
| Texas Tech University | College/University | Graduate Degree | |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Western Ontario | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Windsor | College/University | Masters Business Admin | |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO | |
| University of Puerto Rico | College/University | Undergraduate Degree | |
| Resolution Pharmaceuticals, Inc. | Director of Finance/CFO | ||
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
| Haas School of Business | College/University | Undergraduate Degree | |
PlantForm Corp.
 PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chairman | |
Syapse, Inc.
 Syapse, Inc. Packaged SoftwareTechnology Services Syapse, Inc. develops software solutions that enable healthcare providers to deploy precision medicine programs. Its medical platform is used to integrate complex genomic and clinical data to provide clinicians with actionable insights at point of care, enabling diagnosis, treatment, and outcomes tracking. The firm offers a suite of clinical applications built on the Syapse Precision Medicine Platform and designed to help healthcare providers implement and scale precision medicine at the point of care. The company was founded by Tony Loeser, Glenn S. Winokur, and Jonathan Hirsch in 2008 and is headquartered in San Francisco, CA. | Packaged Software | Director of Finance/CFO | |
| Emory University School of Medicine | College/University | Corporate Officer/Principal | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | General Counsel | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director of Finance/CFO | |
| Kcnq2 Cure Alliance, Inc. | Director/Board Member | ||
| ACHIEVE LIFE SCIENCES, INC. | Pharmaceuticals: Major | Founder | |
Global Genes
 Global Genes Miscellaneous Commercial ServicesCommercial Services Global Genes is a non-profit organization that connects, empowers, and inspires the rare disease community to become more effective on their own behalf. The non-profit company is based in Aliso Viejo, CA and has subsidiaries in the United States. The company serve more than 400 million people around the globe and nearly one in 10 Americans affected by rare diseases. The organization helps spur innovation, meet essential needs, build capacity and knowledge, and drive progress within and across rare diseases. Global Genes was founded in 2008 and the CEO is Craig Martin. | Miscellaneous Commercial Services | Director/Board Member | |
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 39 |
| Canada | 11 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 4 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 60 |
| Corporate Officer/Principal | 38 |
| Director of Finance/CFO | 24 |
| Independent Dir/Board Member | 24 |
| Chairman | 22 |
Relations les plus connectées
| Insiders | |
|---|---|
| Erich Maximilian Platzer | 31 |
| Bernd Seizinger | 23 |
| Caroline Loewy | 17 |
| Denis Burger | 16 |
| Stephen B. Howell | 16 |
| C. Payne | 14 |
| Warren Whitehead | 14 |
| Carol Ashe | 9 |
| William Rice | 7 |
| Jotin Marango | 7 |
| Mark Vincent | 6 |
| Gregory K. Chow | 6 |
| Victor Montalvo-Lugo | 6 |
| George Melko | 4 |
| Roger Davies | 3 |
- Bourse
- Insiders
- Rafael Bejar
- Connexions Sociétés
